EP4628491A1 — Synthesis of intermediates for the preparation of neurokinin-3 receptor antagonists
Assigned to Quimica Sintetica SA · Expires 2025-10-08 · 1y expired
What this patent protects
The present invention relates to synthetic processes for the preparation of compounds having activity as neurokinin-3-receptor agonists, among which Fezolinetant, and of intermediates useful in the synthesis thereof.
USPTO Abstract
The present invention relates to synthetic processes for the preparation of compounds having activity as neurokinin-3-receptor agonists, among which Fezolinetant, and of intermediates useful in the synthesis thereof.
Drugs covered by this patent
- Veozah (FEZOLINETANT) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.